RPID - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Rapid Micro Biosystems

The unwavering trust of global pharma behemoths in Rapid Micro Biosystems (RPID) contrasts with the internal success of a disciplined management team that has implemented a transparent subscription model. The year-over-year sales trend over a 12-month period demonstrates growth dynamics, with the value recorded at 15.80. The company's innovative optical systems have radically accelerated microbiological control, ensuring the highest safety standards in the production of modern vaccines.
פילוחי נתונים אנליטיים מרוכזים עבור Rapid Micro (RPID)

Rapid Micro Biosystems (RPID) automates microbiological control in pharmaceuticals by implementing the Growth Direct system to minimize production defects. The current 12-month YoY revenue growth rate of 15.80 reflects the actual dynamics of market share expansion, measuring the percentage change in sales over a rolling year to isolate organic growth from inflationary effects.